Company intelligence / Profile preview

BeyondSpring Inc.

Florham Park, New Jersey, USAbeyondspringpharma.com ↗

Ownership: Public · BYSI
Development stage: Phase 3

Overview

The company’s lead asset, Plinabulin, has demonstrated significant overall survival benefit and improved quality of life in phase III trials for NSCLC patients who have failed platinum-based therapies. It also shows strong efficacy in preventing chemotherapy-induced neutropenia. Additional investigator-led studies are ongoing in SCLC and other cancers. Preclinical programs include novel immuno-oncology assets and targeted protein degraders through its subsidiary SEED Therapeutics.[8][9]

Therapeutic areas: OncologyNeurology
Modalities: Small molecules (e.g., Plinabulin, a tubulin binder and dendritic cell maturation agent)Targeted Protein Degradation (via SEED Therapeutics' molecular glue platform)
Industry: Biotech

Drug pipeline

4 assets

plinabulin

3 more assets in the full pipeline.

Request access →

Financials

Market cap: $25.5M
Total revenue: $0
Enterprise value: $19.1M

Beyond the preview

Go deeper on BeyondSpring Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BeyondSpring Inc..

Explore the full profile